January 18, 2017 3:28 AM ET

Pharmaceuticals

Company Overview of Boehringer Ingelheim Ltd UK

Company Overview

Boehringer Ingelheim Ltd UK researches, develops, and manufactures prescription medicines, over-the-counter products, and animal healthcare products in the United Kingdom. The company focuses on various medical conditions, including respiratory, cardiovascular, virology, central nervous system, immunology, and metabolic diseases. It offers products for the treatment of chronic obstructive pulmonary disease, heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, HIV/AIDS, Parkinson's disease, stroke, cerebrovascular disease, diabetes, and non-small cell lung cancer. The company also offers consumer healthcare products in the areas of constipation...

Ellesfield Avenue

Bracknell,  RG12 8YS

United Kingdom

Founded in 1955

Phone:

44 13 4442 4600

Fax:

44 13 4474 1444

Key Executives for Boehringer Ingelheim Ltd UK

Managing Director
Finance & Administration Director
Senior Vice President of Global Biopharma Operations
Head of Established Markets
Compensation as of Fiscal Year 2016.

Boehringer Ingelheim Ltd UK Key Developments

Boehringer Ingelheim Limited Presents at 9th Annual BioPharm America International Partnering Conference - BioPharm America 2016, Sep-14-2016 10:00 AM

Boehringer Ingelheim Limited Presents at 9th Annual BioPharm America International Partnering Conference - BioPharm America 2016, Sep-14-2016 10:00 AM. Venue: Marriott Copley Place, Boston, Massachusetts, United States. Speakers: Imran Nasrullah.

Boehringer Ingelheim Limited Wins GBP 106.5 Million Multiple Awardees Contract for Proprietary Pharmaceuticals

Boehringer Ingelheim Ltd. won a GBP 106.5 million multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for proprietary pharmaceuticals (Contract Award Notice No.: 2016/S 044-072447). NHS Framework Agreement for Proprietary Pharmaceuticals for the Midlands and East Pharmacy Purchasing Group: Period 1.3.2016 to 28.2.2018 with an option to extend for 24 months. Hepatitis C drugs for the above region: Period 1.3.2016 to 28.2.2017 with an option to extend for 12 months.

Boehringer Ingelheim Ltd Wins GBP 567.5 Million Multiple Awardees Contract for Pharmaceutical Products

Boehringer Ingelheim Ltd. won a GBP 567.5 million (excluding VAT) multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for pharmaceutical products (Contract Award Notice No.: 2016/S 023-036546).

Similar Private Companies By Industry

Company Name Region
Abbey Pharma Limited Europe
Absynth Biologics Limited Europe
Acacia Pharma Limited Europe
AccentBio Ltd. Europe
Aclar Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Boehringer Ingelheim Ltd UK, please visit www.boehringer-ingelheim.co.uk. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.